ClinicalTrials.govpublic full text
Assessment of Clinical Practice Administration of Chemotherapy and Anti-angiogenic Agent (Bevacizumab) in Colorectal Cancer
metastatic colorectal cancer, mcrc, kras mutation, chemotherapy, anti-angiogenic agent, bevacizumab, 1st line, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 890276
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.